Relationship between immunosuppression and intensive care unit-acquired colonization and infection related to multidrug-resistant bacteria: a prospective multicenter cohort study
- PMID: 36592202
- DOI: 10.1007/s00134-022-06954-0
Relationship between immunosuppression and intensive care unit-acquired colonization and infection related to multidrug-resistant bacteria: a prospective multicenter cohort study
Abstract
Purpose: The impact of immunosuppression on intensive care unit (ICU)-acquired colonization and infection related to multidrug-resistant (MDR) bacteria (ICU-MDR-col and ICU-MDR-inf, respectively) is unknown.
Methods: We carried out an observational prospective cohort study in 8 ICUs in France (all with single-bed rooms and similar organizational characteristics). All consecutive patients with an ICU stay > 48 h were included, regardless of immune status, and followed for 28 days. Patients underwent systematic screening for colonization with MDR bacteria upon admission and every week subsequently. Immunosuppression was defined as active cancer or hematologic malignancy, neutropenia, solid-organ transplant, use of steroids or immunosuppressive drugs, human immunodeficiency virus infection and genetic. The primary endpoint was the incidence rate of a composite outcome including ICU-MDR-col and/or ICU-MDR-inf.
Results: 750 patients (65.9% males, median age 65 years) were included, among whom 264 (35.2%) were immunocompromised. Reasons for ICU admission, severity scores and exposure to invasive devices and antibiotics during ICU stay were comparable between groups. After adjustment for center and pre-specified baseline confounders, immunocompromised patients had a lower incidence rate of ICU-MDR-col and/or ICU-MDR-inf (adjusted incidence ratio 0.68, 95% CI 0.52-0.91). When considered separately, the difference was significant for ICU-MDR-col, but not for ICU-MDR-inf. The distribution of MDR bacteria was comparable between groups, with a majority of Enterobacteriacae resistant to third-generation cephalosporins (~ 74%).
Conclusion: Immunocompromised patients had a significantly lower incidence rate of a composite outcome including ICU-MDR-col and/or ICU-MDR-inf. This finding points to the role of contact precautions and isolation measures, and could have important implications on antibiotic stewardship in this population.
Keywords: Antimicrobial resistance; Cross infection; Immunocompromised host; Intensive Care Unit; Patient isolation.
© 2022. Springer-Verlag GmbH Germany, part of Springer Nature.
Comment in
-
Multidrug-resistant bacteria in the grey shades of immunosuppression.Intensive Care Med. 2023 Feb;49(2):216-218. doi: 10.1007/s00134-022-06968-8. Epub 2023 Jan 23. Intensive Care Med. 2023. PMID: 36688974 No abstract available.
-
Relationship of multidrug-resistant bacterial colonization and immune status of patients in the ICU.Intensive Care Med. 2023 Apr;49(4):479-480. doi: 10.1007/s00134-023-07003-0. Epub 2023 Feb 28. Intensive Care Med. 2023. PMID: 36853335 No abstract available.
References
-
- Murray CJ, Ikuta KS, Sharara F et al (2022) Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Lancet 399:629–655. https://doi.org/10.1016/S0140-6736(21)02724-0 - DOI
-
- De Waele JJ, Boelens J, Leroux-Roels I (2020) Multidrug-resistant bacteria in ICU: fact or myth. Curr Opin Anaesthesiol 33:156–161. https://doi.org/10.1097/ACO.0000000000000830 - DOI - PubMed
-
- Vincent J-L, Rello J, Marshall J et al (2009) International study of the prevalence and outcomes of infection in intensive care units. JAMA 302:2323–2329. https://doi.org/10.1001/jama.2009.1754 - DOI - PubMed
-
- Masse J, Elkalioubie A, Blazejewski C et al (2017) Colonization pressure as a risk factor of ICU-acquired multidrug resistant bacteria: a prospective observational study. Eur J Clin Microbiol Infect Dis 36:797–805. https://doi.org/10.1007/s10096-016-2863-x - DOI - PubMed
-
- Barbier F, Pommier C, Essaied W et al (2016) Colonization and infection with extended-spectrum β-lactamase-producing Enterobacteriaceae in ICU patients: what impact on outcomes and carbapenem exposure? J Antimicrob Chemother 71:1088–1097. https://doi.org/10.1093/jac/dkv423 - DOI - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
